Research Org. Must Pay $3M For Not Filling Up Clinical Trial
An arbitrator has ordered clinical research organization inVentiv to pay Cel-Sci Corp. nearly $3 million for breaching their contract by underfilling a phase three clinical trial testing a head and neck...To view the full article, register now.
Already a subscriber? Click here to view full article